ATYR aTyr Pharma Inc Total Asset Value of Company
aTyr Pharma, Inc. (ATYR) specializes in tRNA therapy, developing efzofitimod to combat pulmonary sarcoidosis without steroid-related risks. The company's price evolution reflects the dynamics of total assets, which are currently fixed at 85.68. The organization is diversifying its portfolio by adapting its developments to meet oncology needs. High brand authority among physicians confirms its status as an innovator in the therapy of severe fibrous lesions.
Analytical breakdowns and data insights for company aTyr (ATYR)
- stock price and consensus target price:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio aTyr Pharma, Inc.|ATYR - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio aTyr Pharmaceuticals|ATYR - Company Aggregate Debts|Debts to Book Capitalization aTyr Pharmaceuticals|ATYR - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings aTyr Pharma|Interim Coverage Ratio atyrpharma.com
- net income and valuation multiples indicators:
Fundamental valuation:aTyr Pharma, Inc.
In the biotechnology sector, the scale of resources determines survivability until product commercialization. By analyzing the change in controlled resources, calculated reverse through ROA, an investor assesses the aggregate asset base of aTyr Pharma, Inc. (ATYR), which is critically important while awaiting final data on sarcoidosis therapy. A high level of assets ensures the issuer's financial stability, minimizing risks until the generation of actual sales revenue.
Key competitors
argenx.com - Aggregate Asset Value|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|RIGL - Company Total Assets|ANAB (AnaptysBio, Inc.) - Cumulative Company Assets|ATXS: Aggregate Business Assets|Cumulative Company Assets ENGN|Company Assets RAPT Therapeutics Inc. RAPT|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Aggregate Asset Value|Kyverna Therapeutics - Cumulative Company Assets|Aggregate Asset Value TLSA|CABA - Aggregate Company Assets|Total Asset Value of Company VTYX|THTX: Company Total Assets|Avalo Therapeutics Inc - Aggregate Asset Value|ELDN (Eledon Pharmaceuticals) - Company Total Assets|Company Total Assets agenusbio.com|Aggregate Company Assets Climb Bio (CLYM)|ZURA (Zura Bio Ltd) - Aggregate Asset Value|Aggregate Company Assets Adagene Inc. ADAG|IMA - Cumulative Company Assets|Shattuck Therapeutics - Company Total Assets|EQ - Company Total Assets|CNTB (connectbiopharm.com) - Cumulative Company Assets|Immunic - Aggregate Asset Value|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|InflaRx GmbH (IFRX) - Company Total Asset Base|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|adicetbio.com - Total Business Assets|Company Total Assets CELU (Celularity)|INMB - Cumulative Company Assets|BRNS: Cumulative Company Assets|Company Total Asset Base Kezar Life Sciences Inc KZR|SABS: Company Total Assets|akaritx.com (AKTX) - Company Total Assets|Cumulative Company Assets ENLV|QTTB (Q32 Bio Corp) - Aggregate Business Assets|Cumulative Company Assets GOVX (GeoVax Labs Inc)|EDSA - Company Assets|Aggregate Company Assets iBio, Inc. IBIO|Aggregate Asset Value CARM|XTLB - Aggregate Company Assets|Total Asset Value of Company BOLT|HCWB: Company Total Assets|Aptevo Therapeutics Inc. - Aggregate Asset Value|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Company Total Assets Aditxt Corp|Aggregate Company Assets GRI Bio (GRI)|XRTX (XORTX Therapeutics Inc) - Aggregate Asset Value|Aggregate Company Assets ReShape Lifesciences HIND|REVB - Cumulative Company Assets|Indaptus Therapeutics - Company Total Assets|SCNI - Company Total Assets|CALI (calcimedica.com) - Cumulative Company Assets|Affimed N.V. - Aggregate Asset Value|ALLK (Allakos Inc) - Company Total Assets|HOOKIPA (HOOK) - Company Total Asset Base|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|Cumulative Company Assets iteostherapeutics.com ITOS|Aggregate Company Assets Ocean Biomedical OCEA|TCBP - Cumulative Company Assets|THRD: Cumulative Company Assets